225 related articles for article (PubMed ID: 29030073)
1. Comparative Analysis of Surgery, Thermal Ablation, and Active Surveillance for Renal Oncocytic Neoplasms.
Miller BL; Mankowski Gettle L; Van Roo JR; Ziemlewicz TJ; Best SL; Wells SA; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Huang W; Abel EJ
Urology; 2018 Feb; 112():92-97. PubMed ID: 29030073
[TBL] [Abstract][Full Text] [Related]
2. Active Surveillance for Renal Neoplasms with Oncocytic Features is Safe.
Richard PO; Jewett MA; Bhatt JR; Evans AJ; Timilsina N; Finelli A
J Urol; 2016 Mar; 195(3):581-6. PubMed ID: 26388501
[TBL] [Abstract][Full Text] [Related]
3. Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma.
Flack CK; Calaway AC; Miller BL; Picken MM; Gondim DD; Idrees MT; Abel EJ; Gupta GN; Boris RS
Urol Oncol; 2019 Nov; 37(11):811.e17-811.e21. PubMed ID: 31451335
[TBL] [Abstract][Full Text] [Related]
4. Reliability and Management Outcomes Following a Percutaneous Biopsy Diagnosis of Oncocytoma: A 15-year Retrospective Analysis.
Chai JL; Alencar RO; Hirsch MS; Bhagavatula S; Bay CP; Siegmund S; Chang SL; Silverman SG
Radiology; 2023 Apr; 307(2):e221156. PubMed ID: 36692400
[TBL] [Abstract][Full Text] [Related]
5. Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms.
Zhu B; Rohan SM; Lin X
Cancer Cytopathol; 2020 Dec; 128(12):962-970. PubMed ID: 32697415
[TBL] [Abstract][Full Text] [Related]
6. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
[TBL] [Abstract][Full Text] [Related]
7. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
[TBL] [Abstract][Full Text] [Related]
8. Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy.
Liu S; Lee S; Rashid P; Bangash H; Hamid A; Lau J; Cohen R
BJU Int; 2016 Oct; 118 Suppl 3():30-34. PubMed ID: 27457972
[TBL] [Abstract][Full Text] [Related]
9. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up.
Alderman MA; Daignault S; Wolf JS; Palapattu GS; Weizer AZ; Hafez KS; Kunju LP; Wu AJ
Hum Pathol; 2016 Sep; 55():1-10. PubMed ID: 27085554
[TBL] [Abstract][Full Text] [Related]
10. Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma.
Meagher MF; Lane BR; Capitanio U; Mehrazin R; Bradshaw AW; Noyes S; Larcher A; Eldefrawy A; Ghali F; Patel D; Bruinius J; Dutt R; Keiner C; Miller N; Wan F; Montorsi F; Derweesh IH
World J Urol; 2021 Apr; 39(4):1195-1201. PubMed ID: 32556559
[TBL] [Abstract][Full Text] [Related]
11. Does renal mass biopsy influence multidisciplinary treatment recommendations?
Lobo JM; Clements MB; Bitner DP; Mikula MD; Noona SW; Sultan MI; Cathro HP; Lambert DL; Schenkman NS; Krupski TL
Scand J Urol; 2020 Feb; 54(1):27-32. PubMed ID: 31868063
[No Abstract] [Full Text] [Related]
12. Growth and renal function dynamics of renal oncocytomas in patients on active surveillance.
Neves JB; Varley R; Agnesi S; Withington J; Rodrigues FB; Warren H; Yuminaga Y; Capitanio U; Rode N; Grant L; Tran-Dang MA; El-Sheikh S; Walkden M; Cullen D; Aitchison M; Patki P; Mumtaz F; Barod R; Bex A; Tran MGB
BJU Int; 2021 Dec; 128(6):722-727. PubMed ID: 34046981
[TBL] [Abstract][Full Text] [Related]
13. Oncocytoma managed by active surveillance in a transplant allograft kidney: a case report.
Pagano D; di Francesco F; Rosa L; Nwaiwu CA; Li Petri S; Gruttadauria S
World J Surg Oncol; 2018 Jul; 16(1):123. PubMed ID: 29966524
[TBL] [Abstract][Full Text] [Related]
14. Real world outcomes of biopsy-proven oncocytic neoplasm of the kidney managed by surveillance.
Rodger FE; Brown K; Leung S; Coode-Bate J; Armitage J; Warren A; Hendry J; Stewart GD; Laird A; Oades GM
BJUI Compass; 2022 Jul; 3(4):291-297. PubMed ID: 35783590
[TBL] [Abstract][Full Text] [Related]
15. Re: Five-Year Analysis of a Multi-Institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry.
Laguna MP
J Urol; 2016 Feb; 195(2):297-8. PubMed ID: 26852966
[No Abstract] [Full Text] [Related]
16. Oncocytoma on renal mass biopsy: is it still the same histology when surgery is performed? Results from UroCCR-104 study.
Branger N; Bigot P; Pignot G; Lorusso V; Audenet F; Parier B; Doumerc N; Brenier M; Xylinas E; Boissier R; Rouprêt M; Champy C; Nouhaud FX; Lang H; Charles T; Mallet R; Ambrosetti D; Bensalah K; Bernhard JC
World J Urol; 2023 Feb; 41(2):483-489. PubMed ID: 36633650
[TBL] [Abstract][Full Text] [Related]
17. Kidney cancer: Surveillance not inferior in SRM.
Thoma C
Nat Rev Urol; 2015 Apr; 12(4):178. PubMed ID: 25732860
[No Abstract] [Full Text] [Related]
18. Active surveillance for bilateral renal oncocytomas already resected on one side: a case report.
Mario S M; Elisa C; Gian D C; Matteo C; Biagio T
Urologia; 2021 May; 88(2):122-124. PubMed ID: 33292059
[TBL] [Abstract][Full Text] [Related]
19. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
20. Management of small renal mass: an opportunity to address a growing problem in early stage kidney cancer.
Jewett MA; Richard PO; Finelli A
Eur Urol; 2015 Sep; 68(3):416-7. PubMed ID: 26004796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
